根据 位华尔街分析师的预测,abrdn World Healthcare Fund 的收入预期范围从 $ 到 $
abrdn World Healthcare Fund 的盈利质量评分是多少?
abrdn World Healthcare Fund 的盈利质量评分为 B+/51.48032。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
abrdn World Healthcare Fund 何时发布财报?
abrdn World Healthcare Fund 的下一份财报预计在 发布
abrdn World Healthcare Fund 的预期收益是多少?
根据华尔街分析师的预测,abrdn World Healthcare Fund 的预期收益为 $
abrdn World Healthcare Fund 是否超出收益预期?
abrdn World Healthcare Fund 最近的收益为 $, 预期。
关键数据
前收盘价
$11.37
开盘价
$11.37
当日区间
$11.18 - $11.5
52周范围
$9.8 - $13.19
交易量
116.3K
平均成交量
165.9K
股息收益率
5.73%
每股收益(TTM)
1.35
市值
$453.8M
什么是 THW?
abrdn World Healthcare Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2015-06-26. abrdn World Healthcare Fund (the Fund), formerly Tekla World Healthcare Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt securities of public and private United States and non-United States companies. The Fund is focused on investing at least 40% of its managed assets in companies organized or located outside the United States or companies that do a substantial amount of business outside the United States. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. The Fund may also invest up to 20% of managed assets in healthcare real estate investment trusts. The Fund invests in sectors, which include biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, healthcare distributors, and others. The Fund’s investment adviser is abrdn Inc.